{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/67105af848726944170ab1fe/67a2a3410ef429ce22b78741?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Katy Rezvani: Allogeneic NK Cells Are Coming to Beat Cancer at a Clinic Near You","description":"<p>Katy Rezvani, MD, PhD, turned her fascination with immunology into a career engineering allogeneic immune cell therapies. On <em>Behind the Breakthroughs</em>, Rezvani explains why NK cells—unlike T cells—hold promise for safer, more accessible cancer treatments, and how her work at MD Anderson is shaping the future of cell therapy.</p><p><br></p><p><em>Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter&nbsp;</em><a href=\"https://www.insideprecisionmedicine.com/newsletter-sign-up/\" rel=\"noopener noreferrer\" target=\"_blank\"><em>here</em></a><em>.</em></p><p><br></p><p><em>Produced by Bill Levine</em></p><p><em>Hosted by Jonathan D. Grinstein, PhD</em></p><p><em>Music provided by Artem Hramushkin</em></p><p><em>Audio mixed and mastered by Jason Mack</em></p>","author_name":"Inside Precision Medicine"}